Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3':5'-cyclic monophosphate levels.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation
1976 • 956 citations
HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
1977 • 886 citations
The chemical structure of prostaglandin X (prostacyclin)
1976 • 729 citations
Modulation of human platelet adenylate cyclase by prostacyclin (PGX)
1977 • 659 citations
Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets
1977 • 601 citations
The release of nucleotides, 5‐hydroxytryptamine and enzymes from human blood platelets during aggregation
1968 • 312 citations
Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men
1978 • 181 citations
RECIRCULATION OF PROSTACYCLIN (PGI2) IN THE DOG
1978 • 167 citations
Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregation
1979 • 135 citations
Studies of a Simplified Plasma Insulin Immunoassay Using Cellulose Powder
1968 • 123 citations
PROSTACYCLIN TO PREVENT PLATELET ACTIVATION DURING CHARCOAL HÆMOPERFUSION IN FULMINANT HEPATIC FAILURE
1980 • 123 citations
A double blind placebo controlled crossover study of prostacyclin in man
1979 • 121 citations
Pulmonary and anti-platelet effects of intravenous and inhaled prostacyclin in man
1978 • 92 citations
Prevention of aspecifically induced bronchoconstriction by PGI2 and 20-methyl-PGI2 in asthmatic patients
1978 • 32 citations